The Digital Pathology Market is expected to witness a steady CAGR of ~10.5% by 2029.
The primary drivers of this market are the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders; the growing use of digital pathology in research; the increasing incorporation of digital pathology in drug discovery and precision medicine programs; the growing acceptance of telepathology; and the adoption of digital pathology to improve efficiency […]
Continue Reading